Okay. I'm going to make it really quick.
Jim and Jody, it's been brought before this committee that under CETA the increase to the cost of drugs would be $850 million to $1.645 billion per year. The overall GDP impact improvement under CETA would be $600 billion, so you can see that there is a clear distinction in how much we'll gain versus how much we will lose, and all Canadians will lose under the cost of drugs.
My question is what will happen to access to affordable generics for Canadians if the amendments that you're proposing are not brought forward?